<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-17241" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Adrenal Insufficiency</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Huecker</surname>
            <given-names>Martin R.</given-names>
          </name>
          <aff>University of Louisville</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Bhutta</surname>
            <given-names>Beenish S.</given-names>
          </name>
          <aff>Sheikh Zayed Hospital, Lahore</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Dominique</surname>
            <given-names>Elvita</given-names>
          </name>
          <aff>Wyckoff Heights Medical Center</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Martin Huecker declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Beenish Bhutta declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Elvita Dominique declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>17</day>
          <month>8</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-17241.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Adrenal glands produce hormones necessary for normal body functioning; the deficiency of these hormones is called adrenal insufficiency. Adrenal insufficiency can present along a spectrum ranging from mild nonspecific symptoms to life-threatening shock. The decrease in adrenal function may be masked until stress or illness triggers an adrenal crisis. This activity reviews the evaluation and management of adrenal insufficiency and highlights the role of interprofessional team collaboration in the recognition and management of adrenal insufficiency.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the etiology of adrenal insufficiency.</p></list-item><list-item><p>Outline the laboratory evaluation for adrenal insufficiency.</p></list-item><list-item><p>Review the treatment options available for adrenal insufficiency.</p></list-item><list-item><p>Summarize some interprofessional strategies that the healthcare team can employ to improve outcomes for patients with adrenal insufficiency.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=17241&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=17241">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-17241.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>The adrenal gland is made up of two parts, the cortex and the medulla. The adrenal cortex produces hormones necessary for normal body functioning; deficiency of these hormones results in adrenal insufficiency. The cortex is responsible for producing glucocorticoids, mineralocorticoids, and androgens. Destruction or dysfunction of the adrenal cortex mainly causes glucocorticoid and mineralocorticoid deficiency. Primary adrenal insufficiency is also known as autoimmune adrenalitis or Addison disease.</p>
        <p>Adrenal insufficiency ranges from mild nonspecific symptoms to life-threatening shock conditions. Due to its vague symptoms and varying degree of clinical presentation, a clinician must maintain a high level of suspicion for this disease. The decreasing or suppressed adrenal function may be masked until stress or illness triggers an adrenal crisis.</p>
        <p>Adrenal insufficiency can be classified into primary, secondary, and tertiary causes. Primary adrenal insufficiency occurs when there is a pathology affecting the adrenal gland itself. Secondary adrenal insufficiency results from a decreased level of adrenocorticotrophin hormone (ACTH) released from the pituitary gland, and tertiary adrenal insufficiency results from a decreased level of corticotrophin-releasing hormone (CRH) released from the hypothalamus.&#x000a0;&#x000a0;</p>
        <p>An important distinction in these patients is the presence of&#x000a0;mineralocorticoid deficiency. Those with secondary or tertiary adrenal insufficiency&#x000a0;will typically have preserved mineralocorticoid function&#x000a0;due to the separate feedback systems. Mineralocorticoid levels are regulated by the renin-angiotensin system that is&#x000a0;independent of hypothalamic or pituitary signals.</p>
        <p>Another important distinction is the acute versus chronic nature of the disease. Acute&#x000a0;adrenal insufficiency&#x000a0;patients often present in a critically ill state, while chronic presentation can be insidious.<xref ref-type="bibr" rid="article-17241.r1">[1]</xref><xref ref-type="bibr" rid="article-17241.r2">[2]</xref><xref ref-type="bibr" rid="article-17241.r3">[3]</xref><xref ref-type="bibr" rid="article-17241.r4">[4]</xref><xref ref-type="bibr" rid="article-17241.r5">[5]</xref></p>
      </sec>
      <sec id="article-17241.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Primary adrenal insufficiency is characterized by decreased aldosterone and cortisol production due to diminished gland function. It can either present acutely, which may present as an adrenal crisis, or it can be chronic, which is called Addison disease.</p>
        <p>The&#x000a0;most common cause of primary adrenal insufficiency/Addison disease relates to the autoimmune destruction of the adrenal cortex. Autobodies form against the steroid 21-hydroxylase enzyme in approximately 90% of patients.<xref ref-type="bibr" rid="article-17241.r6">[6]</xref>&#x000a0;Other insults to the adrenal gland that lead to primary insufficiency include adrenal hemorrhage, cancer, infections (HIV, syphilis, tuberculosis), and certain drugs such as etomidate, ketoconazole, fluconazole, or metyrapone. Phenytoin and rifampin increase the metabolism of cortisol and can, therefore, precipitate&#x000a0;adrenal insufficiency&#x000a0;in those predisposed.<xref ref-type="bibr" rid="article-17241.r7">[7]</xref></p>
        <p>Adrenal hemorrhage can occur in patients taking anticoagulants or have a bleeding diathesis, or in the postoperative setting.&#x000a0;</p>
        <p>Primary adrenal insufficiency can also be congenital. Congenital adrenal hyperplasia has been extensively studied and described in the literature. Panhypopituitarism and many genetic conditions can cause adrenal insufficiency. Pituitary hemorrhage or infarction (Sheehan syndrome) can cause secondary adrenal insufficiency. Other causes include pituitary tumors, hypophysectomy, and high dose pituitary or whole-brain radiation.<xref ref-type="bibr" rid="article-17241.r8">[8]</xref></p>
        <p>Brain tumors and abrupt withdrawal from long term exogenous steroid use can cause tertiary adrenal insufficiency.</p>
      </sec>
      <sec id="article-17241.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>As many as 144 million individuals in the developed world may have Addison disease. When treated properly, patients can have a roughly normal lifespan. Untreated patients have a high mortality rate.<xref ref-type="bibr" rid="article-17241.r9">[9]</xref><xref ref-type="bibr" rid="article-17241.r10">[10]</xref></p>
        <p>The autoimmune form of&#x000a0;adrenal insufficiency has a male-female predisposition based on the type of&#x000a0;autoimmune condition. Females are more likely to have a polyglandular form, while isolated adrenal damage is more common in males in the first two&#x000a0;decades. By the fourth decade, the isolated form is more common in women.</p>
        <p>Due to the diverse causes of&#x000a0;adrenal insufficiency, no distinct group of individuals is at increased risk of disease.</p>
        <p>The epidemiology of adrenal insufficiency in children is not well-defined. Congenital adrenal hyperplasia (CAH) is the most common etiology of primary adrenal insufficiency in children, occurring once in 14,200 live births.<xref ref-type="bibr" rid="article-17241.r11">[11]</xref></p>
      </sec>
      <sec id="article-17241.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>The pathophysiology of&#x000a0;adrenal insufficiency&#x000a0;depends on the etiology. With most forms of autoimmune (primary) adrenal insufficiency, the patient has antibodies that attack various enzymes in the adrenal cortex (though cell-mediated mechanisms also contribute). Various genetic factors have been identified that play a role in developing primary adrenal insufficiency or autoimmune adrenalitis. These include the major histocompatibility complex (MHC) haplotypes&#x000a0;DR3-DQ2 and DR4-DQ8.<xref ref-type="bibr" rid="article-17241.r12">[12]</xref></p>
        <p>Secondary&#x000a0;adrenal insufficiency&#x000a0;refers to decreased adrenocorticotropic&#x000a0;hormone (ACTH) stimulation of the adrenal cortex and, therefore, does not affect aldosterone levels. Traumatic brain injury (TBI) and panhypopituitarism are common causes.<xref ref-type="bibr" rid="article-17241.r13">[13]</xref></p>
        <p>Tertiary&#x000a0;adrenal insufficiency&#x000a0;refers to decreased hypothalamic stimulation of the pituitary to secrete ACTH. Exogenous steroid administration is the most common cause of tertiary&#x000a0;adrenal insufficiency. Surgery to correct Cushing disease can also lead to tertiary&#x000a0;adrenal insufficiency.</p>
        <p>The other forms of&#x000a0;adrenal insufficiency&#x000a0;usually relate to destruction by infectious agents or infiltration by metastatic malignant cells. Hemorrhagic infarction occurs due to sepsis with certain organisms (<italic toggle="yes">Neisseria </italic>species<italic toggle="yes">,</italic> tuberculosis, fungal infections,<italic toggle="yes">&#x000a0;Streptococcus&#x000a0;</italic>species<italic toggle="yes">, Staphylococcus&#x000a0;</italic>species<italic toggle="yes">)&#x000a0;</italic>or adrenal vein thrombosis. Death associated with adrenal insufficiency is usually of septic shock, hypotension, or cardiac arrhythmias.<xref ref-type="bibr" rid="article-17241.r14">[14]</xref><xref ref-type="bibr" rid="article-17241.r15">[15]</xref></p>
      </sec>
      <sec id="article-17241.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>The adrenal cortex is divided into three layers, each responsible for producing a specific hormone. Histopathology varies according to the pathological process involved in adrenal gland dysfunction. In autoimmune adrenalitis, there is atrophy of the adrenal gland with infiltration of lymphocytes along with fibrosis of the adrenal capsule. As adrenal insufficiency is caused by dysfunction of the cortex, the adrenal medulla is not affected and is spared&#x02014;adrenal insufficiency due to tuberculosis results in enlargement of the adrenal glands with caseating granulomas. The adrenal medulla is usually not spared, and the gland is characterized by diffuse calcification.<xref ref-type="bibr" rid="article-17241.r16">[16]</xref></p>
        <p>In patients with acquired immunodeficiency syndrome (AIDS), there is infarction, hemorrhage, and necrotizing inflammation of the adrenal gland.<xref ref-type="bibr" rid="article-17241.r17">[17]</xref></p>
      </sec>
      <sec id="article-17241.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Patients with adrenal insufficiency often present with hypotension, altered mental status, anorexia, vomiting, weight loss, fatigue, and recurrent abdominal pain. Reproductive complaints typically occur in women (amenorrhea, loss of libido, decreased axillary and pubic hair). Salt craving and orthostatic hypotension are common in patients with primary adrenal insufficiency due to the volume depletion from the reduced mineralocorticoid function. Obtaining a history of exogenous corticosteroid use is crucial in making the diagnosis, especially in chronic&#x000a0;adrenal insufficiency cases.</p>
        <p>Patients may have poor skin turgor and increased skin&#x000a0;pigmentation. Patients may also manifest neuropsychiatric signs and symptoms. One might notice&#x000a0;signs of Cushing syndrome, such as skin atrophy, striae, edema, obesity, muscle wasting, and neuropsychiatric disturbance.</p>
        <p>As many as half of the patients will develop&#x000a0;shock with no preceding hypotension. Hypotension can be present in any form of&#x000a0;adrenal insufficiency. Fever should lead to an investigation for infectious etiology, although it can be present in any form of&#x000a0;adrenal insufficiency.<xref ref-type="bibr" rid="article-17241.r5">[5]</xref><xref ref-type="bibr" rid="article-17241.r18">[18]</xref><xref ref-type="bibr" rid="article-17241.r6">[6]</xref></p>
      </sec>
      <sec id="article-17241.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>The diagnosis of primary adrenal insufficiency requires suspicion as it mostly presents with non-specific symptoms. Hyponatremia with hyperkalemia and hypoglycemia may be present. Serum cortisol, ACTH, renin, aldosterone, and chemistry panel should be obtained. Serum cortisol level can help make diagnoses in the presence of elevated ACTH and plasma renin activity. The ACTH stimulation test can be performed to determine if the cause is central or peripheral.<xref ref-type="bibr" rid="article-17241.r19">[19]</xref></p>
        <p>The initial testing in primary adrenal insufficiency should be to measure anti-21-hydroxylase antibodies as these are responsible for the destruction of the adrenal cortex.<xref ref-type="bibr" rid="article-17241.r20">[20]</xref></p>
        <p>Patients with secondary&#x000a0;adrenal insufficiency&#x000a0;are more likely to have hypoglycemia but will not have dehydration, hyperkalemia, or skin hyperpigmentation.</p>
        <p>Adrenal insufficiency presenting later in life is mostly due to a secondary cause. Consider testing for HIV and tuberculosis in patients with unclear&#x000a0;etiology. Adrenal insufficiency due to tuberculosis is more common in patients belonging to developing countries.<xref ref-type="bibr" rid="article-17241.r21">[21]</xref><xref ref-type="bibr" rid="article-17241.r22">[22]</xref></p>
        <p>The most common laboratory findings in chronic primary&#x000a0;adrenal insufficiency&#x000a0;are anemia, hyponatremia, and hyperkalemia.</p>
      </sec>
      <sec id="article-17241.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>
<bold>Treatment of Chronic Primary Adrenal Insufficiency</bold>
</p>
        <p>
<bold>1. Glucocorticoid replacement (one of the given regimens):</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Hydrocortisone</bold> 15 to 25 mg orally in two or three divided doses (the largest dose is taken early in the &#x000a0;morning; typically 10 mg upon awakening in the morning, 5 mg early afternoon, 2.5 mg late afternoon), or</p>
          </list-item>
          <list-item>
            <p><bold>Prednisone</bold> 5 mg (2.5 to 7.5 mg) orally at bedtime, or</p>
          </list-item>
          <list-item>
            <p><bold>Dexamethasone</bold> 0.75 mg (0.25 to 0.75 mg) orally at bedtime</p>
          </list-item>
          <list-item>
            <p>Monitor clinical symptoms and morning plasma ACTH as needed.</p>
          </list-item>
        </list>
        <p>
<bold>2. Mineralocorticoid replacement:</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Fludrocortisone</bold> 0.1 mg (range: 0.05 to 0.2 mg) orally. Hydrocortisone 20 mg and prednisone 50 mg provide a mineralocorticoid effect that is almost equivalent to 0.1 mg of fludrocortisone. Therefore, fludrocortisone replacement (if needed) must be decreased accordingly. Dexamethasone, however, lacks a mineralocorticoid effect and would require a full dose of fludrocortisone.</p>
          </list-item>
          <list-item>
            <p>Liberal salt intake.</p>
          </list-item>
          <list-item>
            <p>Monitor supine and standing blood pressure as well as pulse, edema, serum potassium, and plasma renin activity</p>
          </list-item>
        </list>
        <p>
<bold>3. Androgen replacement:</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Dehydroepiandrosterone (DHEA)</bold> initially 25 to 50 mg orally (only in women for psychological well-being, if needed, after optimal glucocorticoid and mineralocorticoid replacement).</p>
          </list-item>
        </list>
        <p>
<bold>4. Patient education:</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Educate the patient about the illness, how to manage stress, and inject dexamethasone or other glucocorticoids intramuscularly or subcutaneously.</p>
          </list-item>
        </list>
        <p>
<bold>5. Emergency precautions:</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Patients should have a medical alert bracelet/necklace, an emergency medical information card on their phone or inside their wallet, and prefilled syringes containing 4 mg of dexamethasone in 1 mL saline.</p>
          </list-item>
        </list>
        <p>
<bold>6. Treatment of minor febrile illness or stress:</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Increase glucocorticoid dose two to three times for the few days of illness. Do not change the mineralocorticoid dose (3x3 rule).</p>
          </list-item>
          <list-item>
            <p>The patient should contact the clinician if the condition worsens or persists for more than three days.</p>
          </list-item>
          <list-item>
            <p>No extra dose is required for most uncomplicated, outpatient dental procedures under local anesthesia.</p>
          </list-item>
          <list-item>
            <p>Glucocorticoid supplement for surgical stress:</p>
          </list-item>
          <list-item>
            <p>Minor: hydrocortisone 25 mg IV (or equivalent) on the day of the procedure</p>
          </list-item>
          <list-item>
            <p>Moderate: hydrocortisone 50 to 75 mg IV (or equivalent) on day of surgery and postoperative day 1</p>
          </list-item>
          <list-item>
            <p>Major: hydrocortisone 100 to 150 mg IV (or equivalent) in two or three divided doses on the day of surgery and postoperative days 1 and 2</p>
          </list-item>
        </list>
        <p>
<bold>7. Emergency treatment of severe stress or trauma:</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Each patient should have an injectable as well as vials of sterile 0.9% normal saline and syringes.</p>
          </list-item>
        </list>
        <p>
<bold>Treatment of Adrenal Crisis</bold>
</p>
        <p>
<bold>Measures to stabilize the patient:</bold>
</p>
        <list list-type="order">
          <list-item>
            <p>Intravenous access with one or two large-gauge needles</p>
          </list-item>
          <list-item>
            <p>Laboratory analysis, including serum electrolytes, glucose, and routine measurement of plasma cortisol and ACTH.</p>
          </list-item>
          <list-item>
            <p>Infusion of 2 to 3 liters of isotonic saline or 5% dextrose in isotonic saline as urgently as possible. Periodic hemodynamic monitoring and measurement of serum electrolytes.</p>
          </list-item>
          <list-item>
            <p>Give hydrocortisone 100 mg intravenous bolus, followed by 50 mg intravenously every 6 hours (or 200 mg/24 hours as a continuous intravenous infusion for the first 24 hours). If hydrocortisone is unavailable, alternatives include prednisolone, prednisone, and dexamethasone.</p>
          </list-item>
          <list-item>
            <p>Correct any ongoing electrolyte abnormalities. Hyponatremia is often corrected by cortisol and volume repletion.</p>
          </list-item>
        </list>
        <p>
<bold>Subacute measures after stabilization of the patient:</bold>
</p>
        <list list-type="order">
          <list-item>
            <p>Intravenous isotonic saline infusion at a slower rate for the next 24 to 48 hours.</p>
          </list-item>
          <list-item>
            <p>Diagnosis and treatment of possible infectious precipitating causes of the adrenal crisis.</p>
          </list-item>
          <list-item>
            <p>If the patient does not have known adrenal insufficiency, a short ACTH stimulation test should establish the diagnosis&#x000a0;and determine its type and cause.</p>
          </list-item>
          <list-item>
            <p>Tapering of parenteral glucocorticoid over 1 to 3 days to the oral glucocorticoid maintenance dose, if there are no ongoing contraindications.</p>
          </list-item>
          <list-item>
            <p>Initiating mineralocorticoid replacement with fludrocortisone, 0.1 mg by mouth daily after stopping the saline infusion.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-17241.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <list list-type="bullet">
          <list-item>
            <p>Adrenal crisis</p>
          </list-item>
          <list-item>
            <p>Adrenal hemorrhage</p>
          </list-item>
          <list-item>
            <p>Congenital adrenal hyperplasia</p>
          </list-item>
          <list-item>
            <p>Eosinophilia</p>
          </list-item>
          <list-item>
            <p>Histoplasmosis</p>
          </list-item>
          <list-item>
            <p>Hyperkalemia</p>
          </list-item>
          <list-item>
            <p>Sarcoidosis</p>
          </list-item>
          <list-item>
            <p>Tuberculosis</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-17241.s11" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>People with adrenal insufficiency can live a normal and active life if they are properly monitored and treated. With proper treatment and regular follow-ups, children grow normally and achieve puberty without difficulty.</p>
      </sec>
      <sec id="article-17241.s12" sec-type="Complications">
        <title>Complications</title>
        <p>The most dangerous complication of adrenal insufficiency is an adrenal crisis.</p>
        <table-wrap id="article-17241.table0" position="float" orientation="portrait">
          <table>
            <tbody>
              <tr>
                <td rowspan="1" colspan="1">
<bold>Clinical and Laboratory Findings of Adrenal Crisis</bold>
</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">Dehydration, hypotension, or shock out of proportion to the severity of current illness</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">Nausea and vomiting with a history of weight loss</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">Abdominal pain</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">Hypoglycemia, unexplained</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">Fever, unexplained</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">Hyponatremia, hyperkalemia, azotemia, hypercalcemia, or eosinophilia</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">Any other autoimmune endocrine deficiency, e.g., hypothyroidism</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">Pigmentation abnormalities</td>
              </tr>
            </tbody>
          </table>
        </table-wrap>
        <p>If left untreated, adrenal crisis can result in death. Frequent low blood sugar levels can increase the risk of hypoglycemic shock.<xref ref-type="bibr" rid="article-17241.r23">[23]</xref></p>
      </sec>
      <sec id="article-17241.s13" sec-type="Consultations">
        <title>Consultations</title>
        <p>An endocrinologist should always be involved in the management of adrenal insufficiency. An infectious disease specialist should be consulted if the clinician suspects adrenal insufficiency secondary to an infective etiology. Surgical oncologists are always consulted in the setting of metastatic disease.</p>
      </sec>
      <sec id="article-17241.s14" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Patients and their family members should be educated on symptoms of adrenal crisis. Early diagnosis and prompt treatment lower the mortality rate. Patients should always carry an emergency medicine shot after consulting with their clinicians.&#x000a0;Finally, all patients diagnosed with adrenal insufficiency should be urged to wear a medical ID bracelet.</p>
      </sec>
      <sec id="article-17241.s15" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>As mentioned above, patients in adrenal crisis manifest nonspecific symptoms and can be difficult to diagnose. Those clinicians who prescribe the glucocorticoids such as prednisone must also be aware of the need to limit the length of&#x000a0;time the patient is on the medication and taper when discontinuing.</p>
      </sec>
      <sec id="article-17241.s16" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Adrenal insufficiency is a life-threatening disorder that can lead to very&#x000a0;high morbidity and mortality if not recognized. Because of the varied presentation, it is best managed by an interprofessional team that consists of an endocrinologist, radiologist, an infectious disease specialist, intensivist, critical care nurse, and a pharmacist. While the cause of adrenal insufficiency is being investigated,&#x000a0;the patient should immediately be managed with corticosteroids and mineralocorticoids because even with treatment, mortality rates remain high. The pharmacist should assist with medication reconciliation and appropriate dosing. Once treatment is initiated, patients need close monitoring by a specially trained critical care nurse with open and rapid communication with the clinicians. Any infection or stress can precipitate adrenal crisis leading to death. Hence, the nurses should educate patients about the symptoms and when to return immediately to the emergency department.<xref ref-type="bibr" rid="article-17241.r24">[24]</xref><xref ref-type="bibr" rid="article-17241.r25">[25]</xref></p>
      </sec>
      <sec id="article-17241.s17">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=17241&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=17241">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/hormones-and-body-chemistry/adrenal-insufficiency/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=17241">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/17241/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=17241">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-17241.s18">
        <title>References</title>
        <ref id="article-17241.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ceccato</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Scaroni</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Central adrenal insufficiency: open issues regarding diagnosis and glucocorticoid treatment.</article-title>
            <source>Clin Chem Lab Med</source>
            <year>2019</year>
            <month>Jul</month>
            <day>26</day>
            <volume>57</volume>
            <issue>8</issue>
            <fpage>1125</fpage>
            <page-range>1125-1135</page-range>
            <pub-id pub-id-type="pmid">30427776</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17241.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shaffer</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Baud</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Lacaze-Masmonteil</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Peltoniemi</surname>
                <given-names>OM</given-names>
              </name>
              <name>
                <surname>Bonsante</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Watterberg</surname>
                <given-names>KL</given-names>
              </name>
            </person-group>
            <article-title>Effect of Prophylaxis for Early Adrenal Insufficiency Using Low-Dose Hydrocortisone in Very Preterm Infants: An Individual Patient Data Meta-Analysis.</article-title>
            <source>J Pediatr</source>
            <year>2019</year>
            <month>Apr</month>
            <volume>207</volume>
            <fpage>136</fpage>
            <page-range>136-142.e5</page-range>
            <pub-id pub-id-type="pmid">30416014</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17241.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kang</surname>
                <given-names>TS</given-names>
              </name>
              <name>
                <surname>Choi</surname>
                <given-names>HY</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>SH</given-names>
              </name>
            </person-group>
            <article-title>Adrenal Insufficiency in a Patient with Acute Myocardial Infarction Plus Shock.</article-title>
            <source>Korean Circ J</source>
            <year>2018</year>
            <month>Dec</month>
            <volume>48</volume>
            <issue>12</issue>
            <fpage>1163</fpage>
            <page-range>1163-1164</page-range>
            <pub-id pub-id-type="pmid">30403022</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17241.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Garrahy</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Thompson</surname>
                <given-names>CJ</given-names>
              </name>
            </person-group>
            <article-title>Hyponatremia and Glucocorticoid Deficiency.</article-title>
            <source>Front Horm Res</source>
            <year>2019</year>
            <volume>52</volume>
            <fpage>80</fpage>
            <page-range>80-92</page-range>
            <pub-id pub-id-type="pmid">32097946</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17241.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Martin-Grace</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Dineen</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Sherlock</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Thompson</surname>
                <given-names>CJ</given-names>
              </name>
            </person-group>
            <article-title>Adrenal insufficiency: Physiology, clinical presentation and diagnostic challenges.</article-title>
            <source>Clin Chim Acta</source>
            <year>2020</year>
            <month>Jun</month>
            <volume>505</volume>
            <fpage>78</fpage>
            <page-range>78-91</page-range>
            <pub-id pub-id-type="pmid">32035851</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17241.r6">
          <label>6</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Alexandraki</surname>
                <given-names>KI</given-names>
              </name>
              <name>
                <surname>Sanpawithayakul</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Grossman</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <chapter-title>Adrenal Insufficiency</chapter-title>
            <person-group person-group-type="editor">
              <name>
                <surname>Feingold</surname>
                <given-names>KR</given-names>
              </name>
              <name>
                <surname>Anawalt</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Blackman</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Boyce</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Chrousos</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Corpas</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>de Herder</surname>
                <given-names>WW</given-names>
              </name>
              <name>
                <surname>Dhatariya</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Dungan</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Hofland</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kalra</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kaltsas</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Kapoor</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Koch</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Kopp</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Korbonits</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kovacs</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Kuohung</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Laferr&#x000e8;re</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Levy</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>McGee</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>McLachlan</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>New</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Purnell</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Sahay</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Shah</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Singer</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Sperling</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Stratakis</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Trence</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Wilson</surname>
                <given-names>DP</given-names>
              </name>
            </person-group>
            <source>Endotext [Internet]</source>
            <publisher-name>MDText.com, Inc.</publisher-name>
            <publisher-loc>South Dartmouth (MA)</publisher-loc>
            <year>2022</year>
            <month>11</month>
            <day>7</day>
            <pub-id pub-id-type="pmid">25905309</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17241.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kara</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Ucakt&#x000fc;rk</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Aydin</surname>
                <given-names>OF</given-names>
              </name>
              <name>
                <surname>Aydin</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Adverse effect of phenytoin on glucocorticoid replacement in a child with adrenal insufficiency.</article-title>
            <source>J Pediatr Endocrinol Metab</source>
            <year>2010</year>
            <month>Sep</month>
            <volume>23</volume>
            <issue>9</issue>
            <fpage>963</fpage>
            <page-range>963-6</page-range>
            <pub-id pub-id-type="pmid">21175098</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17241.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shivaprasad</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Sheehan's syndrome: Newer advances.</article-title>
            <source>Indian J Endocrinol Metab</source>
            <year>2011</year>
            <month>Sep</month>
            <volume>15 Suppl 3</volume>
            <issue>Suppl3</issue>
            <fpage>S203</fpage>
            <page-range>S203-7</page-range>
            <pub-id pub-id-type="pmid">22029025</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17241.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rushworth</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>Torpy</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Stratakis</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Falhammar</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Adrenal Crises in Children: Perspectives and Research Directions.</article-title>
            <source>Horm Res Paediatr</source>
            <year>2018</year>
            <volume>89</volume>
            <issue>5</issue>
            <fpage>341</fpage>
            <page-range>341-351</page-range>
            <pub-id pub-id-type="pmid">29874655</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17241.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Meyer</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Badenhoop</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>[Addisonian Crisis - Risk Assessment and Appropriate Treatment].</article-title>
            <source>Dtsch Med Wochenschr</source>
            <year>2018</year>
            <month>Mar</month>
            <volume>143</volume>
            <issue>6</issue>
            <fpage>392</fpage>
            <page-range>392-396</page-range>
            <pub-id pub-id-type="pmid">29544234</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17241.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Neary</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Nieman</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Adrenal insufficiency: etiology, diagnosis and treatment.</article-title>
            <source>Curr Opin Endocrinol Diabetes Obes</source>
            <year>2010</year>
            <month>Jun</month>
            <volume>17</volume>
            <issue>3</issue>
            <fpage>217</fpage>
            <page-range>217-23</page-range>
            <pub-id pub-id-type="pmid">20375886</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17241.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mitchell</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Pearce</surname>
                <given-names>SH</given-names>
              </name>
            </person-group>
            <article-title>Autoimmune Addison disease: pathophysiology and genetic complexity.</article-title>
            <source>Nat Rev Endocrinol</source>
            <year>2012</year>
            <month>Jan</month>
            <day>31</day>
            <volume>8</volume>
            <issue>5</issue>
            <fpage>306</fpage>
            <page-range>306-16</page-range>
            <pub-id pub-id-type="pmid">22290360</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17241.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Alexandraki</surname>
                <given-names>KI</given-names>
              </name>
              <name>
                <surname>Grossman</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Management of Hypopituitarism.</article-title>
            <source>J Clin Med</source>
            <year>2019</year>
            <month>Dec</month>
            <day>05</day>
            <volume>8</volume>
            <issue>12</issue>
            <pub-id pub-id-type="pmid">31817511</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17241.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nassoro</surname>
                <given-names>DD</given-names>
              </name>
              <name>
                <surname>Mkhoi</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Sabi</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Meremo</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Lawala</surname>
                <given-names>PS</given-names>
              </name>
              <name>
                <surname>Mwakyula</surname>
                <given-names>IH</given-names>
              </name>
            </person-group>
            <article-title>Adrenal Insufficiency: A Forgotten Diagnosis in HIV/AIDS Patients in Developing Countries.</article-title>
            <source>Int J Endocrinol</source>
            <year>2019</year>
            <volume>2019</volume>
            <fpage>2342857</fpage>
            <pub-id pub-id-type="pmid">31341472</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17241.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ventura Spagnolo</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Mondello</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Roccuzzo</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Stassi</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Cardia</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Grieco</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Raffino</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>A unique fatal case of Waterhouse-Friderichsen syndrome caused by Proteus mirabilis in an immunocompetent subject: Case report and literature analysis.</article-title>
            <source>Medicine (Baltimore)</source>
            <year>2019</year>
            <month>Aug</month>
            <volume>98</volume>
            <issue>34</issue>
            <fpage>e16664</fpage>
            <pub-id pub-id-type="pmid">31441842</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17241.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Guo</surname>
                <given-names>YK</given-names>
              </name>
              <name>
                <surname>Yang</surname>
                <given-names>ZG</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Ma</surname>
                <given-names>ES</given-names>
              </name>
              <name>
                <surname>Deng</surname>
                <given-names>YP</given-names>
              </name>
              <name>
                <surname>Min</surname>
                <given-names>PQ</given-names>
              </name>
              <name>
                <surname>Yin</surname>
                <given-names>LL</given-names>
              </name>
              <name>
                <surname>Hu</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>XC</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>TW</given-names>
              </name>
            </person-group>
            <article-title>Addison's disease due to adrenal tuberculosis: contrast-enhanced CT features and clinical duration correlation.</article-title>
            <source>Eur J Radiol</source>
            <year>2007</year>
            <month>Apr</month>
            <volume>62</volume>
            <issue>1</issue>
            <fpage>126</fpage>
            <page-range>126-31</page-range>
            <pub-id pub-id-type="pmid">17182208</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17241.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Eledrisi</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Verghese</surname>
                <given-names>AC</given-names>
              </name>
            </person-group>
            <article-title>Adrenal insufficiency in HIV infection: a review and recommendations.</article-title>
            <source>Am J Med Sci</source>
            <year>2001</year>
            <month>Feb</month>
            <volume>321</volume>
            <issue>2</issue>
            <fpage>137</fpage>
            <page-range>137-44</page-range>
            <pub-id pub-id-type="pmid">11217816</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17241.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Harbeck</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Lehnert</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>[Diagnosis and Management of Adrenal Insufficiency].</article-title>
            <source>Dtsch Med Wochenschr</source>
            <year>2018</year>
            <month>Aug</month>
            <volume>143</volume>
            <issue>17</issue>
            <fpage>1242</fpage>
            <page-range>1242-1249</page-range>
            <pub-id pub-id-type="pmid">30134456</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17241.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cole</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Evaluation and Treatment of Adrenal Dysfunction in the Primary Care Environment.</article-title>
            <source>Nurs Clin North Am</source>
            <year>2018</year>
            <month>Sep</month>
            <volume>53</volume>
            <issue>3</issue>
            <fpage>385</fpage>
            <page-range>385-394</page-range>
            <pub-id pub-id-type="pmid">30100004</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17241.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Reznik</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Barat</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Bertherat</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Bouvattier</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Castinetti</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Chabre</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Chanson</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Cortet</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Delemer</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Goichot</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Gruson</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Guignat</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Proust-Lemoine</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Sanson</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Reynaud</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Boustani</surname>
                <given-names>DS</given-names>
              </name>
              <name>
                <surname>Simon</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Tabarin</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Zenaty</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>SFE/SFEDP adrenal insufficiency French consensus: Introduction and handbook.</article-title>
            <source>Ann Endocrinol (Paris)</source>
            <year>2018</year>
            <month>Feb</month>
            <volume>79</volume>
            <issue>1</issue>
            <fpage>1</fpage>
            <page-range>1-22</page-range>
            <pub-id pub-id-type="pmid">29338844</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17241.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Reddy</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Tuberculoma of the pituitary gland presenting as diabetes insipidus.</article-title>
            <source>Neurol India</source>
            <year>2017</year>
            <season>Jul-Aug</season>
            <volume>65</volume>
            <issue>4</issue>
            <fpage>909</fpage>
            <page-range>909-911</page-range>
            <pub-id pub-id-type="pmid">28681785</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17241.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Paragliola</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Corsello</surname>
                <given-names>SM</given-names>
              </name>
            </person-group>
            <article-title>Secondary adrenal insufficiency: from the physiopathology to the possible role of modified-release hydrocortisone treatment.</article-title>
            <source>Minerva Endocrinol</source>
            <year>2018</year>
            <month>Jun</month>
            <volume>43</volume>
            <issue>2</issue>
            <fpage>183</fpage>
            <page-range>183-197</page-range>
            <pub-id pub-id-type="pmid">28750490</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17241.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fischer</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Stallmach</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Fanconi</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Adrenal crisis presenting as hypoglycemic coma.</article-title>
            <source>Intensive Care Med</source>
            <year>2000</year>
            <month>Jan</month>
            <volume>26</volume>
            <issue>1</issue>
            <fpage>105</fpage>
            <page-range>105-8</page-range>
            <pub-id pub-id-type="pmid">10663290</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17241.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Annane</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Pastores</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Rochwerg</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Arlt</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Balk</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Beishuizen</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Briegel</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Carcillo</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Christ-Crain</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Cooper</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Marik</surname>
                <given-names>PE</given-names>
              </name>
              <name>
                <surname>Umberto Meduri</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Olsen</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Rodgers</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Russell</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Van den Berghe</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Guidelines for the diagnosis and management of critical illness-related corticosteroid insufficiency (CIRCI) in critically ill patients (Part I): Society of Critical Care Medicine (SCCM) and European Society of Intensive Care Medicine (ESICM) 2017.</article-title>
            <source>Intensive Care Med</source>
            <year>2017</year>
            <month>Dec</month>
            <volume>43</volume>
            <issue>12</issue>
            <fpage>1751</fpage>
            <page-range>1751-1763</page-range>
            <pub-id pub-id-type="pmid">28940011</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17241.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Guignat</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Therapeutic patient education in adrenal insufficiency.</article-title>
            <source>Ann Endocrinol (Paris)</source>
            <year>2018</year>
            <month>Jun</month>
            <volume>79</volume>
            <issue>3</issue>
            <fpage>167</fpage>
            <page-range>167-173</page-range>
            <pub-id pub-id-type="pmid">29606279</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
